Real-world (RW) Survival and Outcomes with Androgen Receptor Pathway Inhibitor (ARPI) –doublet Therapy in Patients (pts) with De Novo Metastatic Castration-Sensitive Prostate Cancer (Mcspc).
Journal of Clinical Oncology（2024）
Key words
261-492-3532-2370-7650-2700,283-183-180-5577-2829-12292,298-11050,283-183-180-5577-10870,261-436-2730,283-183-180-5577-10870
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined